RECBIO-B(02179),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02179 RECBIO-B

Not Yet Opened 12-08 09:00:00

5.500

+0.000

0.00%

High5.500	Low5.500	Vol0.00
Open5.500	D1 Closing5.500	Amplitude0.00%
Mkt Cap2.66B	Tradable Cap1.74B	Total Shares482.96M
T/O0.00	T/O Rate0.00%	Tradable Shares316.14M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02179","market":"HK","secType":"STK","nameCN":"RECBIO-B","latestPrice":5.5,"timestamp":1765155600056,"preClose":5.5,"halted":0,"volume":0,"delay":0,"floatShares":316138689,"shares":482963000,"eps":-1.2817006175967134,"marketStatus":"Not Yet Opened","change":0,"latestTime":"12-08 09:00:00","open":5.5,"high":5.5,"low":5.5,"amount":0,"amplitude":0,"askPrice":5.5,"askSize":38500,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.494542080607513,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765243800000},"marketStatusCode":0,"adr":0,"listingDate":1648656000000,"exchange":"SEHK","adjPreClose":5.5,"openAndCloseTimeList":[[1765157400000,1765166400000],[1765170000000,1765180800000]],"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02179","defaultTab":"news","newsList":[{"id":"1188962762","title":"Jiangsu Recbio (2179) Announces Extraordinary General Meeting on December 19, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1188962762","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188962762?lang=en_us&edition=fundamental","pubTime":"2025-12-01 23:01","pubTimestamp":1764601315,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (stock code: 2179) is scheduled to convene its first extraordinary general meeting of 2025 on December 19, 2025 at 10:00 a.m., at Conference Room, 3/F, Building...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"gpt_icon":0},{"id":"1144747535","title":"Jiangsu Recbio (Stock Code: 2179) Announces 2025 First Extraordinary General Meeting Details","url":"https://stock-news.laohu8.com/highlight/detail?id=1144747535","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144747535?lang=en_us&edition=fundamental","pubTime":"2025-12-01 23:01","pubTimestamp":1764601273,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (Stock Code: 2179) has issued a notice regarding its 2025 first extraordinary general meeting (EGM), scheduled for December 19, 2025, at 10:00 a.m. The venue will...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"gpt_icon":0},{"id":"2588536776","title":"Jiangsu Recbio Technology Co. Ltd. Announces Date for First Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2588536776","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588536776?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:50","pubTimestamp":1764600647,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co. Ltd. will hold its 2025 First Extraordinary General Meeting on December 19, 2025, at the Conference Room, 3/F, Building G29, Standard Plant, China Medical City Phase 6, Medical High-tech District, Taizhou City, Jiangsu Province, China. During the meeting, shareholders will consider and vote on a special resolution to approve the proposed abolishment of the Supervisory Board and amendments to the Articles of Association and its attachments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 01, 2025, and is solely respo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL9wDrgB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2588776538","title":"BRIEF-Jiangsu Recbio Technology Says Li Bu Resigned As Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2588776538","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588776538?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:50","pubTimestamp":1764600642,"startTime":"0","endTime":"0","summary":"BRIEF-Jiangsu Recbio Technology Says Li Bu Resigned As Executive DirectorDec 1  - Jiangsu Recbio Technology Co Ltd 2179.HK:LI BU RESIGNED AS EXECUTIVE DIRECTORCHEN QINGQING RESIGNED AS AN EXECUTIVE DIRECTORHONG KUNXUE RESIGNED AS EXECUTIVE DIRECTORNOMINATED WEI QIFANG AND WANG JING AS EXECUTIVE DIRECTORSFurther company coverage: 2179.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X70SA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02179"],"gpt_icon":0},{"id":"1192355521","title":"Jiangsu Recbio (2179) Announces Updated Committee Terms of Reference","url":"https://stock-news.laohu8.com/highlight/detail?id=1192355521","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192355521?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:42","pubTimestamp":1764600121,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (Stock code: 2179) published revised terms of reference for its Board’s Remuneration and Appraisal Committee. The document outlines the committee’s role in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"gpt_icon":0},{"id":"1177075496","title":"RECBIO-B (02179) Nominates Wei Qifang and Wang Jing as Executive Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=1177075496","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177075496?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:16","pubTimestamp":1764598577,"startTime":"0","endTime":"0","summary":"RECBIO-B (02179) announced that its board of directors received resignation letters from Mr. Li Bu, Ms. Chen Qingqing, and Dr. Hong Kunxue on December 1, 2025. Mr. Li Bu resigned as an executive...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2588773235","title":"Jiangsu Recbio Files Director List with HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2588773235","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588773235?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:10","pubTimestamp":1764598226,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co. Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The Board is chaired by Executive Director Dr. Liu Yong. Non-executive Directors include Dr. Wang Ruwei, Dr. Zhang Jiaxin, Dr. Zhou Hongbin, and Mr. Hu Houwei. The Independent Non-executive Directors are Dr. Xia Lijun, Mr. Liang Guodong, Professor Gao Feng, and Professor Yuen Ming Fai. Dr. Liu Yong serves as Chairman of the Nomination Committee. Dr. Zhou Hongbin is a member of the Audit Committee. Dr. Xia Lijun chairs the Audit Committee and is a member of both the Remuneration and Appraisal Committee and the Nomination Committee. Mr. Liang Guodong and Professor Gao Feng are members of the Remuneration and Appraisal Committee and Nomination Committee. Professor Yuen Ming Fai chairs the Remuneration and Appraisal Committee and is a member of the Audit Committee.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL4sVty:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2588773197","title":"Jiangsu Recbio Technology Co Ltd - Li Bu Resigned as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2588773197","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588773197?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:05","pubTimestamp":1764597938,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X70SA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2588477319","title":"Jiangsu Recbio Technology - Nominated Wei Qifang and Wang Jing as Executive Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2588477319","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588477319?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:05","pubTimestamp":1764597938,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X70SA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2588191773","title":"Jiangsu Recbio Technology Co Ltd - Hong Kunxue Resigned as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2588191773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588191773?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:05","pubTimestamp":1764597938,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X70SA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2588773167","title":"Jiangsu Recbio Announces Resignation of Three Executive Directors and Moves to Abolish Supervisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2588773167","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588773167?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:05","pubTimestamp":1764597908,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co. Ltd. has announced the resignation of Mr. Li Bu, Ms. Chen Qingqing, and Dr. Hong Kunxue from their positions as executive directors. Additionally, Mr. Li Bu has stepped down as an authorised representative, and Ms. Chen Qingqing has resigned as a joint company secretary. The company also plans to abolish its supervisory board, with the Audit Committee under the Board assuming supervisory functions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 01, 2025, and is solely responsible for the information contained there","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL7LcCsf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2583857787","title":"Jiangsu Recbio Receives Approval for Expanded Production of Recombinant Shingles Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2583857787","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583857787?lang=en_us&edition=fundamental","pubTime":"2025-11-14 18:51","pubTimestamp":1763117466,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co. Ltd. announced that it has received an addition to its Drug Production License from the Jiangsu Provincial Drug Administration. The approval allows the company to expand its production to include the recombinant shingles vaccine  and related adjuvant components at its facilities in Taizhou, Jiangsu Province. This development strengthens Recbio's research and production capabilities in the field of preventive biological products and sets the stage for future marketing and registration of the vaccine. No other organizations were reported to have received this grant or approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL1C33Mv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2582346933","title":"Jiangsu Recbio Technology Co., Ltd.'s (HKG:2179) market cap dropped HK$398m last week; Retail investors bore the brunt","url":"https://stock-news.laohu8.com/highlight/detail?id=2582346933","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582346933?lang=en_us&edition=fundamental","pubTime":"2025-11-12 10:29","pubTimestamp":1762914597,"startTime":"0","endTime":"0","summary":"Key Insights The considerable ownership by retail investors in Jiangsu Recbio Technology indicates that they...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2179/jiangsu-recbio-technology-shares/news/jiangsu-recbio-technology-co-ltds-hkg2179-market-cap-dropped","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2179/jiangsu-recbio-technology-shares/news/jiangsu-recbio-technology-co-ltds-hkg2179-market-cap-dropped","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"1184208164","title":"Jiangsu Recbio Technology Co., Ltd. (02179) Announces October 2025 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1184208164","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184208164?lang=en_us&edition=fundamental","pubTime":"2025-11-03 14:11","pubTimestamp":1762150301,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. (02179) released its monthly return for October 2025, detailing movements in share capital and issued shares. According to the announcement, the company's total...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"gpt_icon":0},{"id":"1111196582","title":"RECBIO-B (02179) Reports Interim Results with Shareholders' Attributable Loss of 341 Million Yuan, Up 36.7% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1111196582","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111196582?lang=en_us&edition=fundamental","pubTime":"2025-08-29 19:24","pubTimestamp":1756466665,"startTime":"0","endTime":"0","summary":"RECBIO-B (02179) announced its interim results for 2025, reporting continuing operations revenue of 10.899 million yuan (RMB, same below), compared to nil in the same period last year. Loss...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2563044089","title":"Jiangsu Recbio Technology H1 Capex RMB 55.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2563044089","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563044089?lang=en_us&edition=fundamental","pubTime":"2025-08-29 19:02","pubTimestamp":1756465338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nPLX98822E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2553773217","title":"Jiangsu Recbio Technology Co. Ltd. Awaits Regulatory Approval for Domestic Share Issuance Amidst Uncertainties","url":"https://stock-news.laohu8.com/highlight/detail?id=2553773217","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553773217?lang=en_us&edition=fundamental","pubTime":"2025-07-23 19:42","pubTimestamp":1753270958,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co., Ltd. has announced that it has received a reply from the China Securities Regulatory Commission  regarding the issuance of domestic shares. The regulatory approval is part of an ongoing review process, and the issuance is contingent upon the fulfillment of certain conditions outlined in previous announcements and circulars. Jiangsu Recbio Technology is committed to keeping its shareholders and potential investors informed about the progress of this issuance in compliance with the Inside Information Provisions and Listing Rules. As of now, there is no indication that the grant or funding involves multiple organizations; it appears to be solely related to Jiangsu Recbio Technology Co., Ltd.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nNDLT6VMh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2547067317","title":"Jiangsu Recbio Technology Enters Partnership with India's Biological E for HPV 9-Valent Vaccine Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2547067317","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547067317?lang=en_us&edition=fundamental","pubTime":"2025-06-30 17:47","pubTimestamp":1751276879,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co. Ltd. has announced a new partnership with India's Biological E Company to collaborate on the recombinant HPV 9-valent vaccine REC603. Under this agreement, Jiangsu Recbio will provide Biological E with the vaccine formulation, filling, and packaging technologies, and will later extend the drug substance production technology. Biological E has been granted exclusive rights to develop, manufacture, and commercialize the vaccine in India and markets led by UNICEF and PAHO. The partnership includes upfront and milestone payments, along with royalties based on annual net sales.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL5jmqmG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2544612580","title":"Jiangsu Recbio Technology Co. Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2544612580","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544612580?lang=en_us&edition=fundamental","pubTime":"2025-06-20 18:03","pubTimestamp":1750413817,"startTime":"0","endTime":"0","summary":"Jiangsu Recbio Technology Co. Ltd. held its annual general meeting on June 20, 2025. During the meeting, the proposal for the appointment of Mr. CHEN Gang as a board observer was approved. Additionally, the amendments to the Articles of Association were considered and approved, with the amended articles set to become effective upon the proposed changes in the company's business scope taking effect.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief on June 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDLbSHDtH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":-0.1603},{"period":"3month","weight":-0.2667},{"period":"6month","weight":-0.3373},{"period":"1year","weight":-0.3357},{"period":"ytd","weight":-0.4211}],"compareEarnings":[{"period":"1week","weight":-0.0103},{"period":"1month","weight":-0.0182},{"period":"3month","weight":-0.0067},{"period":"6month","weight":0.0574},{"period":"1year","weight":0.297},{"period":"ytd","weight":0.2844}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Jiangsu Recbio Technology Co Ltd is a China-based company mainly engaged in the research and development of vaccines. The Company has a portfolio of clinical-stage and pre-clinical stage vaccines, and its human papilloma virus (HPV) vaccine pipelines comprise of recombinant HPV 9-valent vaccine REC603, recombinant HPV 9-valent vaccines REC601 and REC602, recombinant HPV quadrivalent vaccine REC604a, and recombinant HPV 9-valent vaccine REC604b. The Company also involves in the development of Covid-19 vaccines. The Company mainly distributes products within domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.071825},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.044398},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.06484},{"month":4,"riseRate":0.25,"avgChangeRate":-0.083572},{"month":5,"riseRate":0.25,"avgChangeRate":-0.027385},{"month":6,"riseRate":0.25,"avgChangeRate":-0.013774},{"month":7,"riseRate":0.5,"avgChangeRate":-0.016314},{"month":8,"riseRate":0.25,"avgChangeRate":-0.033938},{"month":9,"riseRate":0.25,"avgChangeRate":-0.012227},{"month":10,"riseRate":0.5,"avgChangeRate":0.027812},{"month":11,"riseRate":0,"avgChangeRate":-0.140794},{"month":12,"riseRate":0.75,"avgChangeRate":0.12598}],"exchange":"SEHK","name":"RECBIO-B","nameEN":"RECBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RECBIO-B(02179),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest RECBIO-B(02179) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"RECBIO-B,02179,RECBIO-B股票,RECBIO-B股票老虎,RECBIO-B股票老虎国际,RECBIO-B行情,RECBIO-B股票行情,RECBIO-B股价,RECBIO-B股市,RECBIO-B股票价格,RECBIO-B股票交易,RECBIO-B股票购买,RECBIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RECBIO-B(02179),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest RECBIO-B(02179) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}